Literature DB >> 12568313

Cytosine residues influence kidney accumulations of 99mTc-labeled morpholino oligomers.

Guozheng Liu1, Jiang He, Surong Zhang, Changbin Liu, Mary Rusckowski, Donald J Hnatowich.   

Abstract

Watson-Crick pairing between complementary oligomers is proving to be an effective means for rapidly directing radioisotopes specifically to the exterior surface of cancer cells in vivo. In such pretargeting applications, it is highly desirable that the excess of isotopically labeled oligomers, which do not bind to the cancer cells, be rapidly cleared from the body. In this context, understanding the influence of chain length and base sequence of the radiolabeled oligomers is critical. We had earlier determined that the kidneys are the principal targets of short-chain radiolabeled morpholino oligomers (MORFs). To explain these observations, MORFs consisting of uniform cytosines (Cs), uniform thymines (Ts), uniform adenines (As), and uniform AAG repeat were labeled with technetium-99m (99mTc) and studied in normal mice. In a limited investigation of the influence of oligomer backbone, a 20-mer MORF (MORF20) with a base sequence rich in Cs was compared with a phosphoromonothioate DNA (S-DNA20) of the same sequence. The in vivo behavior of the labeled MORFs was nearly identical in all organs, with the exception of kidneys. The kidney accumulations were about 25- to 80-fold higher for the uniform Cs relative to the other three uniform MORFs at 3 hours. The S-DNA20 rich in Cs showed only modest kidney accumulations compared with the equivalent MORF20, presumably because of preferential clearance of the S-DNA20 through the liver. Urine analysis showed no evidence of intact labeled S-DNA20 in contrast to fully intact labeled MORF20. We conclude that the high kidney levels observed by us previously for MORFs are most likely due largely to the C residues in the base sequence. In the case of S-DNAs, this phenomenon is partly disguised by the increased hepatic excretion and degradation. These results show that the base sequences of MORFs, and probably other oligomers as well, are an important determinant of biodistribution.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12568313     DOI: 10.1089/108729002321082465

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  13 in total

1.  Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.

Authors:  Guozheng Liu; Shuping Dou; Mary Rusckowski; Dale Greiner; Donald Hnatowich
Journal:  Appl Radiat Isot       Date:  2010-03-06       Impact factor: 1.513

2.  Improved delivery in cell culture of radiolabeled antisense DNAs by duplex formation.

Authors:  Xinrong Liu; Kayoko Nakamura; Yi Wang; Surong Zhang; Jiang He; Guozheng Liu; Shuping Dou; Atsushi Kubo; Mary Rusckowski; Donald Hnatowich
Journal:  Mol Imaging Biol       Date:  2006 Sep-Oct       Impact factor: 3.488

3.  A self-assembling short oligonucleotide duplex suitable for pretargeting.

Authors:  Prabodhika Mallikaratchy; Jeffery Gardner; Lars Ulrik R Nordstrøm; Nicholas J Veomett; Michael R McDevitt; Mark L Heaney; David A Scheinberg
Journal:  Nucleic Acid Ther       Date:  2013-07-13       Impact factor: 5.486

4.  In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles.

Authors:  Yi Wang; Xinrong Liu; Kayoko Nakamura; Ling Chen; Mary Rusckowski; Donald J Hnatowich
Journal:  Cancer Biother Radiopharm       Date:  2009-10       Impact factor: 3.099

5.  Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.

Authors:  Guozheng Liu; Shuping Dou; George Mardirossian; Jiang He; Surong Zhang; Xinrong Liu; Mary Rusckowski; Donald J Hnatowich
Journal:  Clin Cancer Res       Date:  2006-08-15       Impact factor: 12.531

6.  (99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents.

Authors:  Ling Chen; Yi Wang; Dengfeng Cheng; Xinrong Liu; Shuping Dou; Guozheng Liu; Donald J Hnatowich; Mary Rusckowski
Journal:  Bioorg Med Chem       Date:  2013-08-28       Impact factor: 3.641

7.  Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.

Authors:  Guozheng Liu; Shuping Dou; Jiang He; Xinrong Liu; Mary Rusckowski; Donald J Hnatowich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02       Impact factor: 9.236

8.  Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.

Authors:  Guozheng Liu; Jiang He; Shuping Dou; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09       Impact factor: 9.236

9.  Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.

Authors:  G Liu; S Dou; P H Pretorius; X Liu; L Chen; M Rusckowski; D J Hnatowich
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-12-15       Impact factor: 2.346

10.  Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.

Authors:  Guozheng Liu; Jiang He; Shuping Dou; Suresh Gupta; Jean-Luc Vanderheyden; Mary Rusckowski; Donald J Hnatowich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-23       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.